RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
 Individual Studies |
|
|---|---|
|
|
Mus musculus
-
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Authors: Willemien A Nienhuis, Ymkje Stienstra, William A Thompson, Peter C Awuah, K Mohammed Abass, Wilson Tuah, Nana Yaa Awua-Boateng, Edwin O Ampadu, Vera Siegmund, Jan P Schouten,…
Lancet 2010 Feb 20 -
A replication clock for Mycobacterium tuberculosis.
Authors: Wendy P Gill, Nada S Harik, Molly R Whiddon, Reiling P Liao, John E Mittler, David R Sherman
Nature medicine 2009 Feb
Thought leaders and organizations working on research involving mycobacterium.
- National Institute of Allergy and Infectious Diseases (NIAID)
- Pharmacia
- Pfizer
- Cadila Pharnmaceuticals
- Abbott
- Institut Pasteur
- Weill Cornell Medical College
- Colorado State University
- University Medical Centre Groningen
- University of Washington Medical Center
-
Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder
conditions: Superficial Transitional Cell Carcinoma
interventions: Mycobacterium w
-
Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma
conditions: Healthy ; Mycobacterium Infections, Atypical
interventions: interferon gamma
-
Mycobacterium avium infection can result in three different kinds of illness in humans
News-Medical. - February 04, 2010 -
[Articles] Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial
Lancet. - February 18, 2010
Community
Patrick Pithua
Gilles François Ndayisaba
-
No NextBio groups were found for “mycobacterium”.
Be the first to start a group and share your interests with others within the NextBio community.
